Top Biotechnology & Medical Research stocks in Australia
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
TLXTelix Pharmaceuticals | AU$5.14bn | 897.23 | n/a |
CU6Clarity Pharmaceuticals | AU$1.18bn | n/a | n/a |
MSBMesoblast | AU$1.17bn | n/a | n/a |
IMMImmutep | AU$534.98m | n/a | n/a |
IMUImugene | AU$509.01m | n/a | n/a |
PYCPYC Therapeutics | AU$429.28m | n/a | n/a |
OPTOpthea | AU$407.63m | n/a | n/a |
RACRace Oncology | AU$238.70m | n/a | n/a |
CGSCogstate | AU$212.50m | 27.76 | n/a |
DXBDimerix | AU$181.13m | n/a | n/a |
PIQProteomics International Laboratories | AU$126.62m | n/a | n/a |
ALAArovella Therapeutics | AU$109.16m | n/a | n/a |
PARParadigm Biopharmaceuticals | AU$93.15m | n/a | n/a |
OCCOrthocell | AU$72.73m | n/a | n/a |
AGNArgenica Therapeutics | AU$69.90m | n/a | n/a |
LTPLtr Pharma | AU$66.92m | n/a | n/a |
ACWActinogen Medical | AU$67.02m | n/a | n/a |
NTINeurotech International | AU$65.99m | n/a | n/a |
PERPercheron Therapeutics | AU$64.91m | n/a | n/a |
ADOAnteotech | AU$52.71m | n/a | n/a |